Therapeutic Asset Ratings

13,150 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Zanidatamab Breast Cancer	MedSIR	P2	B (56)
Zanidatamab Neoplasm	Haihua Yuan	P2	B (56)
Zanubrutinib Large B-Cell Lymphoma	Ruijin Hospital	P2	B (56)
Zanubrutinib MALT Lymphoma	SWOG Cancer Research Network	P2	B (56)
Zanubrutinib Nodal Marginal Zone B-Cell Lymphoma	SWOG Cancer Research Network	P2	B (56)
(Z)-Endoxifen Breast Carcinoma	National Cancer Institute (NCI)	P2	B (56)
Ziv-Aflibercept Metastatic Melanoma	National Cancer Institute (NCI)	P2	B (56)
zt006 Obesity Disorder	Beijing QL Biopharmaceutical Co.,Ltd	P2	B (56)
1-235-TUMOR NECROSIS FACTOR RECEPTOR (HUMAN) FUSION PROTEIN WITH 236-467-IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN FC FRAGMENT), DIMER Alzheimer Disease	Fondation Ophtalmologique Adolphe de Rothschild	P2	CCC (55)
177lu-dota-eb-fapi radionuclide therapy Refractory Malignant Neoplasm	The First Affiliated Hospital of Xiamen University	P2	CCC (55)
177lu-psma Prostate Cancer	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	P2	CCC (55)
17b-estradiol Breast Cancer	Mary D Chamberlin	P2	CCC (55)
188re-sss lipiodol Hepatocellular Carcinoma	Center Eugene Marquis	P2	CCC (55)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)- Non-Hodgkin Lymphoma	National Cancer Institute (NCI)	P2	CCC (55)
2-deoxy-d-glucose Epilepsy	University of Virginia	P2	CCC (55)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Breast Disorder	Beni-Suef University	P2	CCC (55)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Bile Duct Cyst	National University of Malaysia	P2	CCC (55)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Choledocholithiasis	National University of Malaysia	P2	CCC (55)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Parkinson Disease	VA Office of Research and Development	P2	CCC (55)
[68Ga]Ga-RM2 Prostate Cancer	IRCCS San Raffaele	P2	CCC (55)
Aadvac1 Alzheimer Disease	Paul S. Aisen	P2	CCC (55)
acd440 gel /g Peripheral Neuropathy	AlzeCure Pharma	P2	CCC (55)
Adagrasib Cancer	Bristol-Myers Squibb	P2	CCC (55)
Adagrasib Metastatic Malignant Neoplasm	Mirati Therapeutics Inc.	P2	CCC (55)
Adavosertib Uterine Corpus Cancer	National Cancer Institute (NCI)	P2	CCC (55)

Showing 2576 to 2600 of 13,150 assets

PreviousPage 104 of 526Next